Skip to main content
Clinical Trials/NCT03923153
NCT03923153CompletedNot Applicable

Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina

Mustafa Kemal University2 sites in 1 country40 target enrollmentStarted: April 15, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
Change of the Inspiratory and expiratory muscle strength (MIP, MEP) from baseline to 8 week

Study Overview

Brief Summary

Stable angina is a cardiac pathology that adversely affects the quality of life of the patient, which develops as a result of narrowing of the coronary vessels developing in atherosclerotic ground and / or impaired oxygen supply-need balance. Studies widely investigated the effects of exercise training in patients with stable angina. No study investigated the effects of inspiratory muscle training in patients with stable angina.Investigators aimed to investigate the effects of inspiratory muscle training on aerobic exercise capacity, quality of life, depression, peripheral and respiratory (MIP, MEP) muscle strength, pulmonary function, dyspnea, fatigue in stable angina patients.

Detailed Description

Patients with stable angina will be included. Primary outcome measurement is inspiratory muscle strength, secondary outcomes are functional exercise capacity, peripheral muscle strength, pulmonary functions, maximal exercise capacity, fatigue, quality of life, depression.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • No contraindication for pulmonary physiotherapy
  • Anjina patients who are clinically stable
  • have no other disease that may affect respiratory function
  • Individuals who have the good cooperation

Exclusion Criteria

  • Patients under the age of 18
  • Pregnancy
  • Active infection
  • Patients with known malignancies
  • patients without consent
  • known arrhythmia, dilated or hypertrophic cardiomyopathy, heart failure (EF <40%)

Outcomes

Primary Outcomes

Change of the Inspiratory and expiratory muscle strength (MIP, MEP) from baseline to 8 week

Time Frame: Baseline, after 8 week

Mouth pressure device( MicroRPM, Micro Medical England)

Secondary Outcomes

  • Change from Baseline Functional exercise capacity at 8 week(Baseline, after 8 week)
  • Change from Pulmonary functions at 8 week(Baseline, after 8 week)
  • Fatigue(Baseline, after 8 week)
  • Depression(Baseline,after 8 week)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Irem Hüzmeli

lecturer

Mustafa Kemal University

Study Sites (2)

Loading locations...

Similar Trials